BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Deals

  GNCC Capital, Inc. Acquires BioCann Pharma S.A.S.

  Company acquires Colombian Based Cannabis Pharmaceutical Grade CBD Oils Producer and Distributor

  February 21, 2019

   · 

  4 min read
• Business

  NPI Expands its European Portfolio in an Effort to Help Brands Penetrate the U.S. Market

  Nutritional Products International (NPI), already known as Europe’s gateway to the U.S. market, is expanding its operations in 2019.

  February 21, 2019

   · 

  2 min read
• Policy

  Development of a Neurovascular Magnetic Particle Imaging system for non-radiative 3D perfusion angiography supported by the National Institutes of Health with a Phase II SBIR award to Magnetic Insight

  Magnetic Insight, Inc., leader in Magnetic Particle Imaging solutions, announced that it was awarded a Small Business Innovation Research Phase II grant from the National Institute of Drug Abuse of the National Institutes of Health under Award Number 2R44DA041814.

  February 21, 2019

   · 

  2 min read
• Business

  Autolus Therapeutics to Announce Financial Results for the Transition Period from October 1, 2018 to December 31, 2018 and Host Conference Call on February 25, 2019

  Autolus Therapeutics plc announced that the company will release its operating and financial results for the transition period from October 1, 2018 to December 31, 2018 before the opening of U.S. markets on Monday, February 25, 2019.

  February 21, 2019

   · 

  2 min read
• Deals

  Teleflex Announces Quarterly Dividend payable March 15, 2019

  Teleflex Incorporated announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents per share of common stock.

  February 21, 2019

   · 

  1 min read
• Business

  Enzyvant Appoints Industry Veteran Rachelle Jacques as Chief Executive Officer

  Enzyvant, a biopharmaceutical company focused on developing transformative therapies for patients with rare diseases, announced the appointment of Rachelle Jacques as Chief Executive Officer.

  February 21, 2019

   · 

  2 min read
• Deals

  The Medicines Company Announces Upcoming Investor Conference Presentations

  The Medicines Company announced today that management will present company overviews at the following conferences

  February 21, 2019

   · 

  1 min read
• Genetown

  Verastem Oncology to Present at the 8th Annual SVB Leerink Global Healthcare Conference

  Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, announced that the Company will present at the 8th Annual SVB Leerink Global Healthcare Conference on Friday, March 1, 2019 at 10:30 a.m. EST in New York, NY.

  February 21, 2019

   · 

  1 min read
• Policy

  Lawsuit Alleges Accounting Firm Armanino Failed to Advise Former Owners of Alliance Family of Companies, Costing Millions

  On Tuesday the former owners of Dallas-based Alliance Family of Companies filed a lawsuit in Dallas County against accounting firm Armanino, LLP, alleging negligence, breach of fiduciary duty, negligent misrepresentation, fraud by nondisclosure, unjust enrichment and exemplary damages.

  February 21, 2019

   · 

  2 min read
• Business

  Medical Marijuana, Inc. Subsidiary HempMeds® Announces Distribution Partnership with Shopaholic Boutique, Inc. and 38 Other Retailers

  Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced that in January 2019 the company secured a partnership with major retailer Shopaholic Boutique, Inc.

  February 21, 2019

   · 

  3 min read